Moreover, intraperitoneal co-injection of a TRPV1 inhibitor and a TRPA1 antagonist in a mouse model of experimental colitis results in a substantial reduction of VH compared to injection of the antagonists separately, suggesting a synergistic effect [97]. This evidence concerns the gene TRPA1 and colitis.